Levetiracetam G.L.

Levetiracetam, the active ingredient in Levetiracetam G.L., is an antiepileptic presented as an injectable solution for intravenous use. It is indicated for the control of partial, generalized tonic‑clonic and myoclonic seizures in both adult and pediatric patients, and is marketed across the European Union. GNH USA supplies Levetiracetam G.L. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types.

Partial seizures: helps achieve seizure control in focal onset epilepsy. Generalized tonic‑clonic seizures: reduces the frequency and severity of convulsive episodes. Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: generalized tiredness. - Headache: mild to moderate cranial pain. - Nausea: occasional upset stomach. - Irritability: mood changes or agitation. - Nasal congestion: mild upper respiratory discomfort.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Mood disorders: depression or suicidal thoughts. - Hematologic changes: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome. - Respiratory depression: difficulty breathing (rare).

When using Levetiracetam injection, clinicians should consider several safety measures. - Renal impairment: adjust dosing or monitor closely. - Hepatic dysfunction: assess liver function before initiation. - Psychiatric history: monitor for mood changes or suicidal ideation. - Pregnancy: evaluate risk‑benefit ratio as safety data are limited. - Concomitant CNS depressants: watch for additive sedation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenobarbital: can reduce antiepileptic effect. - Phenytoin: potential decrease in seizure control.

Moderate Interactions (Monitor Closely): - Sedative agents (e.g., benzodiazepines): may enhance CNS depression. - Opioids: increased risk of respiratory depression. - Alcohol: additive sedation and dizziness.